DE60036563D1 - Nukleoprotein des toscanavirus - Google Patents

Nukleoprotein des toscanavirus

Info

Publication number
DE60036563D1
DE60036563D1 DE60036563T DE60036563T DE60036563D1 DE 60036563 D1 DE60036563 D1 DE 60036563D1 DE 60036563 T DE60036563 T DE 60036563T DE 60036563 T DE60036563 T DE 60036563T DE 60036563 D1 DE60036563 D1 DE 60036563D1
Authority
DE
Germany
Prior art keywords
nucleoprotein
virus
toscana
tuscanavirus
toscana virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60036563T
Other languages
English (en)
Other versions
DE60036563T2 (de
Inventor
Maria Grazia Cusi
Marcello Valassina
Pier Egisto Valensin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Siena
Original Assignee
Universita degli Studi di Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Siena filed Critical Universita degli Studi di Siena
Application granted granted Critical
Publication of DE60036563D1 publication Critical patent/DE60036563D1/de
Publication of DE60036563T2 publication Critical patent/DE60036563T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
DE60036563T 1999-12-16 2000-12-18 Nucleoprotein des toscanavirus Expired - Lifetime DE60036563T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9929783.0A GB9929783D0 (en) 1999-12-16 1999-12-16 Toscana virus nucleoprotein
GB9929783 1999-12-16
PCT/IB2000/002031 WO2001044288A2 (en) 1999-12-16 2000-12-18 Toscana virus nucleoprotein

Publications (2)

Publication Number Publication Date
DE60036563D1 true DE60036563D1 (de) 2007-11-08
DE60036563T2 DE60036563T2 (de) 2008-07-17

Family

ID=10866464

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036563T Expired - Lifetime DE60036563T2 (de) 1999-12-16 2000-12-18 Nucleoprotein des toscanavirus

Country Status (10)

Country Link
EP (1) EP1237571B1 (de)
AT (1) ATE374040T1 (de)
AU (1) AU2390101A (de)
CY (1) CY1107607T1 (de)
DE (1) DE60036563T2 (de)
DK (1) DK1237571T3 (de)
ES (1) ES2293934T3 (de)
GB (1) GB9929783D0 (de)
PT (1) PT1237571E (de)
WO (1) WO2001044288A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298423A (en) * 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins
ITMI980889A1 (it) * 1998-04-24 1999-10-24 Diesse Diagnostica Nucleoproteina ricombinante del virus toscana

Also Published As

Publication number Publication date
EP1237571A2 (de) 2002-09-11
AU2390101A (en) 2001-06-25
CY1107607T1 (el) 2013-03-13
DE60036563T2 (de) 2008-07-17
WO2001044288A2 (en) 2001-06-21
DK1237571T3 (da) 2008-01-02
EP1237571B1 (de) 2007-09-26
PT1237571E (pt) 2007-12-31
GB9929783D0 (en) 2000-02-09
WO2001044288A3 (en) 2002-01-24
ES2293934T3 (es) 2008-04-01
ATE374040T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
ATE320493T1 (de) Modifizierung des hepatitis b kernantigens
HUP0401606A2 (hu) West Nile vakcina
WO2009072767A3 (en) A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant
EA200801798A1 (ru) Виросомоподобные везикулы, содержащие антигены, производные от gp41
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
DE60039715D1 (de) Hcv-impfstoff zusammensetzungen
UY26882A1 (es) Nuevo tratamiento
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
PL1949913T3 (pl) Immunostymulująca kombinacja do profilaktyki i leczenia wirusowego zapalenia wątroby typu c
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
EP1305042A4 (de) Zusammensetzungen und methoden zur behandlung von schleimhautinfektionen
DE60036563D1 (de) Nukleoprotein des toscanavirus
ATE378351T1 (de) Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
EA201401044A1 (ru) Модифицированный вирус болезни марека и вакцины на его основе
AR027738A1 (es) Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas
CY1107374T1 (el) Εμβολιο ιχθυος εναντι της piscirickettsia salmonis
TH1901003185A (th) วัคซีนสุกร

Legal Events

Date Code Title Description
8364 No opposition during term of opposition